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ABSTRACT
•M
 esenchymal in origin, solitary fibrous tumors (SFTs) are primarily seen within the pleura
of the lung or in serosal-lined body cavities. Constituting 1-2% of all soft-tissue tumors,
solitary fibrous tumors are rare entities, especially when found in extra-pleural locations.
Diagnosis requires tissue sampling and staining for immunohistochemical markers.
Management of these tumors is based on wide-local excision with histologically negative
margins. If negative margins cannot be surgically achieved, adjuvant therapies including
radiation have been described.
• In this report, we describe a 74-year-old male with an extra-pleural dermal solitary fibrous
tumor. We present the clinical course, surgical procedure, histopathologic features, as well
as discuss the treatment options. We also review the published literature reports of dermal
solitary fibrous tumors.
• With extra-pleural manifestations of solitary fibrous tumors seldom reported in the
literature, it is our hope that reporting these unusual instances will raise awareness of such
disease manifestations and allow for earlier diagnosis and treatment.

CASE REPORT
• 7 4-year-old male was evaluated by Dermatology for a mass on his shoulder
− L ocated on posterior shoulder over right trapezius muscle
− P resent for last 3 years, but rapidly increasing in size in last 2 months
− P ainless and without any associated symptoms
− 3 x 3 cm palpable, non-tender mobile mass noted
• S ignificant past medical history included actinic keratoses
• Incisional biopsy performed by Dermatology and pathology showed:
− S pindle-cell tumor without necrosis, but up to 6 mitoses/10 HPF
− IHC positivity for CD34 & CD99
− P athology reviewed at Johns Hopkins University – Department of Pathology and
diagnosis confirmed with IHC positivity for STAT6
Figure 1. A representative routine H&E section at 20x
magnification showing mitosis and low-grade atypia

Figure 2. A representative IHC stain at 10x magnification showing positivity for CD34

INTRODUCTION
• S FTs are a spindle-cell neoplasm that is mesenchymal in origin
•G
 enerally benign, they are well-circumscribed, mobile, and painless
• If malignant, the most common site of metastasis is the lungs [1]
•M
 ost commonly found in pleural of lung and/or on serosal surfaces
• Associated symptoms can include hypoglycemia, arthralgia, osteoarthritis, and clubbing [1]
•M
 ost commonly affect adults from 40 – 70 years old [1]
•O
 verall all prevalence low, representing 1-2% of all soft-tissue tumors with extra-pleural
SFTs representing 0.6% of all soft tissue tumors [4]
• F ewer than 850 cases of extra-pleural SFTs have been described in the medical literature
worldwide
•D
 iagnosis requires sampling and subsequent histopathologic analysis
− Immunohistochemical (IHC) staining can be used to identify gene expression of
CD34, bcl-2, CD99, and STAT6 and are used as reliable surrogates for detection and
diagnosis of SFTs [2]
−C
 ytogenetic features concerning for metastatic disease include:

• P athologic diagnosis of SFTs requires recognition of histologic features coupled with supportive
positivity of IHC stains
• S imilar to their pleural counter parts, this spindle-cell neoplasm showed evidence of characteristic
gaping and bifurcating staghorn vessels (Figure 4) and alternating areas of hyper and hypocellularity
(Figure 5)

Figure 5. A representative H&E section at 4x
magnification showing alternating areas of
hypo and hypercellularity

•H
 yalinization of vessels is a subtle feature to make the diagnosis
• K ey IHC positive staining for CD34 (Figure 2) is indicative of perivascular cells, the putative origin of
SFTs [2, 3]
• CD99 and bcl-2 can also show variable staining, but these stains are not lineage specific [2]
• A recurrent paracentric inversion involving chromosome 12q13 has been identified in SFTs in the
pleura and soft tissues that results in NAB2-STAT6 gene fusion [7]
− These fusion results in oncogenic overexpression of activation factor STAT6 that drives tumor proliferation
− Identification of STAT6 by IHC confirms the diagnosis (Figure 3)

• P atient evaluated by Surgical Oncology:
− Well-healing incisional biopsy without satellitosis
−C
 T chest, abdomen, and pelvis negative for metastatic disease
− R eferral to Multidisciplinary Cutaneous Oncology Clinic without recommendation for
neoadjuvant therapy
• Wide-local full-thickness excision performed with 1 cm margins
− Trapezius muscle taken for oncological boundary of safety
−D
 efect reconstructed with local rotational-advancement flap
− P ermanent pathology revealed positive deep margins
• After discussion, patient elected to forgo secondary surgery and pursue radiation therapy
with plans for 30 total treatments
Figure 3. A representative IHC stain at 10x magnification showing positivity for STAT6

Figure 4. Rrepresentative routine H&E section at 10x
magnification showing vessels & perivascular tumor growth

		• D
 iameter > 5 cm, significant pleomorphism, atypia, high cellularity, tumor cell necrosis, & > 4
mitotic figures /10 HPF [3]

• Work-up includes staging with computed tomography
•B
 enign tumors are managed with wide-local excision, while metastatic tumors may require
radiation or anti-angiogenic medical therapies
− 5 year-survival for benign tumors ranges from 89-100% [4]
•B
 ecause of malignant potential, SFTs require long-term surveillance

DISCUSSION
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•R
 eported recurrence and metastasis rates range from 10-37% [9]
• F ailure to remove all tumor capsule by wide-local excision has a higher rate of recurrence, but can be
minimized with adjuvant radiation therapy
• In this case, the patient was found to have positive margins, but elected to forgo additional surgery
and to pursue adjuvant radiation therapy
• With extra-pleural SFTs seldom reported in the literature, it is our hope that presenting our
experience will raise awareness of the disease and allow for earlier diagnosis and treatment of such
tumors
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